AM

Advanced Medical Solutions Group PLCLSE Advanced Medical Stock Report

Last reporting period 31 Dec, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.683

Micro

Exchange

XLON - London Stock Exchange

AMS.L Stock Analysis

AM

Neutral

Based on Eyestock quantitative analysis, AMS.L`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

64/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-0.9 %

Overvalued

Market cap $B

0.683

Dividend yield

1.12 %

Shares outstanding

216.54 B

Advanced Medical Solutions Group Plc engages in the design, development, manufacture and distribution of wound care products, surgical dressings, medical grade materials, and medical adhesives and sutures for closing and sealing tissue. The company is headquartered in Winsford, Cheshire. The company went IPO on 2002-04-30. The company manufactures a range of products and materials that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats. The firm operates through two business units for its sales, marketing and research and development (R&D) activities, which include Surgical and Woundcare. Its Surgical business unit is focused on selling and marketing its branded products and are sold directly through its distributors. Its Woundcare business unit is focused on distribution and marketing its products that are supplied to medical device partners under its own brands. The firm offers its products under ActivHeal, LiquiBand and RESORBA brands.

View Section: Eyestock Rating